The precision nutrition market is estimated at USD 6.09 billion in 2024 and is projected to reach USD 12.89 billion by 2029, at a CAGR of 16.2% from 2024 to 2029. Advances in genomics, multi-omics technologies, and AI-driven analytics bring high personalization of dietary recommendations, fueling growth in the precision nutrition market. Increasing demand from consumers for personalized health solutions, mainly because of growing consciousness of the well-established science behind diet-disease prevention, are the factors fueling growth. Furthermore, the rising incidence of lifestyle disorders, combined with the switch towards preventive healthcare models, has increased the adoption rate of precision nutrition. Supportive government policies, investments in research work, and expansions by healthcare providers in wellness programs are other factors that accelerate the growth of the market.
Viome Life Sciences, Inc. (US)
Viome is a direct-to-consumer company with a key focus on tests that uniquely analyze both the microbial and human expressions of genes, or mRNAs, through patented technology licensed by Los Alamos National Laboratory. Its product portfolio consists of three Intelligence Tests: a series of products that include its flagship, the Full Body Intelligence Test, using RNA sequencing to offer deep insights about the oral microbiome, gut microbiome, and cellular health. Viome applies gene expression analysis to provide individual insights into health and nutrition recommendations on a customized scale.
To know about the assumptions considered for the study download the pdf brochure
DayTwo Inc (US)
Day Two is a precision health company focused on chronic management of diabetes, prediabetes, and clinical obesity through individualized solutions. Leveraging highly advanced microbiome analysis and a proprietary AI-driven algorithm, the Day Two predicts blood sugar response to specific foods and food combinations and equips users with better-informed dietary choices. With over 85,000 samples from one of the largest and most comprehensive microbiome datasets worldwide, the company's clinically proven approach places it at the forefront of health solutions derived from the microbiome.
ZOE Limited (UK)
ZOE is a health technology company advancing science combined with artificial intelligence to help people improve their health. Through convenient testing at home, it delivers information related to blood fats, blood sugars, and gut microbiome health, which enables users to have a very personalized nutritional experience. Using such food-scoring evidence from 0 to 100 according to individual biology helps in guiding users toward making informed dietary choices. It provides recommendations for food swaps, additions, and combinations to maximize health along with the option to retest and track improvements in the microbiome over time.
Related Reports:
Precision Nutrition Market by Technology (Metabolomics, Genomics, Transcriptomics, Proteomics), Application (Disease Management, General Health & Wellness, Weight Management), Service Type, End-Use, Supplement, and Region - Global Forecast to 2029
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE